Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
TNF alpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Petra Kleinbongard et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction
Wei He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action
Yajing Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Tumor Necrosis Factor-α and Its Receptors 1 and 2 Yin and Yang in Myocardial Infarction?
Rainer Schulz et al.
CIRCULATION (2009)
Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure Role of Nuclear Factor-κB and Inflammatory Activation
Tariq Hamid et al.
CIRCULATION (2009)
Up-regulation of cell adhesion molecule genes in human endothelial cells stimulated by Lymphotoxin alpha: DNA microarray analysis
Shinichiro Suna et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2008)
TNFR1 and TNFR2 signaling interplay in cardiac myocytes
Nicole Defer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Lymphotoxin-α gene 252A>G and metabolic syndrome features in Korean men with coronary artery disease
Yangsoo Jang et al.
CLINICA CHIMICA ACTA (2007)
Tumor necrosis factor-α in mechanic trauma plasma mediates cardiomyocyte apoptosis
Shuzhuang Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Tumor necrosis factor-α is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction
Yoshiya Monden et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress
Ling Tao et al.
CIRCULATION (2007)
Tumor necrosis factor-α receptor p75 is required in ischemia-induced neovascularization
David A. Goukassian et al.
CIRCULATION (2007)
Effect of the 252A>G polymorphism of the lymphotoxin-α-gene on inflammatory markers of response to cigarette smoking in Korean healthy men
Yangsoo Jang et al.
CLINICA CHIMICA ACTA (2007)
Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes
Zequan Yang et al.
CIRCULATION (2006)
Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-α-induced cardiomyopathy
Y Higuchi et al.
CIRCULATION (2004)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Cardioprotective effects of thioredoxin in myocardial ischemia and the reperfusion role of S-nitrosation
L Tao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro
K Ozaki et al.
NATURE (2004)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Loss of lymphotoxin-α but not tumor necrosis factor-α reduces atherosclerosis in mice
SA Schreyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy
T Kubota et al.
CIRCULATION (2000)